EyePoint Pharmaceuticals Inc

NASDAQ:EYPT  
4.64
-0.25 (-5.11%)
6:57:53 PM EDT: $4.87 +0.23 (+4.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)150.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.45 Million
Adjusted EPS-$0.61
See more estimates
10-Day MA$4.60
50-Day MA$3.59
200-Day MA$7.24
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 123

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.